All terms
Joint Clinical Assessment
EU-wide clinical assessment of high-risk medical devices and IVDs.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Under the EU HTA Regulation (EU) 2021/2282, the Joint Clinical Assessment provides a single clinical evaluation across EU member states for selected high-risk devices and IVDs, beginning 2026 for devices, with national pricing and reimbursement decisions remaining country-specific.What this means in practice
Aims to reduce duplicate national clinical assessments. PICO definition, comparator selection, and evidence package are critical.Primary references
3 sourcesLink health: 1 verified 2 needs review· last checked 2026-05-09
European Commission·1CMS·2
- 1
EU HTA RegulationVerifiedEuropean Commissionhealth.ec.europa.eu
- 2
CMS - CoverageNeeds reviewCMScms.gov
- 3
CMS - CodingNeeds reviewCMScms.gov
Inline markers like [1] jump to the matching reference above.